11.05

2.40% 0.2474

Palatin Technologies Inc. (PTN)

Overview News Price History Option Chain Discussions Forecast Stock Split

Palatin Technologies Inc. stock is traded at $11.05, with a volume of 5,048. It is up +2.40% in the last 24 hours and up +11,652% over the past month. Palatin Technologies, Inc., a biopharmaceutical company, develops targeted, receptor-specific therapeutics for the treatment of various diseases in the United States. The company's principal product is Vyleesi, an on demand subcutaneous injectable product that has completed Phase III clinical studies for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder. Its drug development programs also include melanocortin receptor system program, such as PL-8177, a selective melanocortin receptor 1 agonist peptide for inflammatory bowel diseases; and PL-8331, a preclinical development candidate for treating ocular inflammation, as well as melanocortin receptor 4 peptides and orally-active small molecules to treat genetic metabolic and obesity disorders. In addition, the company develops natriuretic peptide receptor systems comprising PL3994, a natriuretic peptide receptor-A agonist, which has completed Phase I clinical study for the treatment of cardiovascular indications; and PL-5028, a dual natriuretic peptide receptor A and C agonist that is in preclinical development for cardiovascular diseases, such as reducing cardiac hypertrophy and fibrosis. Palatin Technologies, Inc. was founded in 1986 and is based in Cranbury, New Jersey.

Previous Close:

$10.80

Open:

$10.8

24h Volume:

5,048

Relative Volume:

0.00

Market Cap:

$18.39M

Revenue:

$7.10M

Net Income/Loss:

$-31.59M

P/E Ratio:

-4.2327

EPS:

-2.61

Net Cash Flow:

$-26.75M

1W Performance:

+11,652%

1M Performance:

+11,652%

6M Performance:

+11,652%

1Y Performance:

+1,084%

1-Day Range:

$10.80

$11.41

1-Week Range:

$7.25

$17.00

52-Week Range:

$0.0866

$17.00

Palatin Technologies Inc. Stock (PTN) Company Profile

Name

Palatin Technologies Inc.

Sector

Healthcare (1137)

Industry

Biotechnology (634)

Phone

609-495-2200

Address

Cedar Brook Corporate Center, 4B Cedar Brook Drive, Cranbury, NJ

Employee

Twitter

@PalatinTech

Next Earnings Date

2024-11-12

Latest SEC Filings

PTN's Discussions on Twitter

Compare PTN with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PTN Palatin Technologies Inc.	11.05	18.39M	7.10M	-31.59M	-26.75M	-2.61
ARGX Argen X Se Adr	919.80	55.90B	3.06B	1.28B	447.35M	19.67
VRTX Vertex Pharmaceuticals Inc	438.22	110.91B	11.74B	3.68B	3.34B	14.19
INSM Insmed Inc	194.95	41.21B	447.02M	-1.18B	-906.14M	-6.1812
ONC Beone Medicines Ltd Adr	384.29	40.48B	4.98B	69.59M	525.67M	0.5197
REGN Regeneron Pharmaceuticals Inc	706.06	72.89B	14.25B	4.58B	3.88B	41.77

Palatin Technologies Inc. Stock (PTN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jun-05-15	Reiterated	Canaccord Genuity	Buy
Jan-12-15	Reiterated	ROTH Capital	Buy
May-23-12	Initiated	Noble Financial	Buy
Jan-23-07	Initiated	Next Generation	Buy

Palatin Technologies Inc. Stock (PTN) Latest News

03:17 AM

Why analysts raise outlook for Palatin Technologies Inc. (PTN) stockQuarterly Profit Summary & Consistent Growth Stock Picks - newser.com

03:17 AM

Nov 16, 2025

Why ETFs are accumulating Palatin Technologies Inc. (PTN) stockMarket Risk Report & Pattern Based Trade Signal System - newser.com

Nov 16, 2025

Can Palatin Technologies Inc. (PTN) stock stage a strong rebound this quarterJuly 2025 Recap & Safe Capital Growth Stock Tips - newser.com

Nov 16, 2025

Nov 15, 2025

Can Palatin Technologies Inc. (PTN) stock attract ESG investments2025 Sector Review & Fast Moving Stock Watchlists - newser.com

Nov 15, 2025

What analyst consensus implies for Palatin Technologies Inc. (PTN) stock2025 Analyst Calls & Low Volatility Stock Suggestions - newser.com

Nov 15, 2025

Nov 13, 2025

Palatin Technologies Reports Strong Q1 2026 Performance - TipRanks

Nov 13, 2025